Estrogen therapy linked to benign breast disease

	Tweet

Postmenopausal women who use estrogen are at increased risk for developing non-cancerous breast disease, according to a report in the Journal of the National Cancer Institute.

This is the only study to date with randomly assigned treatments to examine the impact of estrogen use on the risk of benign disease, lead researcher Dr. Thomas E. Rohan, from the Albert Einstein College of Medicine in the Bronx, New York, told Reuters Health.

“The central finding was that (estrogen) was associated with an increased risk of benign...breast disease. I was not surprised by the finding” since prior studies had suggested that might be the case, he added. 

The study involved 10,739 postmenopausal women who were assigned to receive estrogen or inactive “placebo” as part of the Women’s Health Initiative CEE trial. Breast examinations and mammograms were performed at enrollment and then annually.

During an average follow-up period of 6.9 years, 232 cases of benign breast disease occurred, the report indicates. Of these cases, 155 arose in the estrogen group and 77 in the placebo group. Thus, estrogen use roughly doubled the risk of benign disease.

Rohan said that the current findings do not change the take-home message for doctors contemplating estrogen therapy for their patients, namely, that the risks and benefits of treatment need to be weighed on an individual basis. The apparent link with benign breast disease is “another item to add to the risk side of the equation.”

SOURCE: Journal of the National Cancer Institute, April 16, 2008.

RELATED STORIES:
Breast Radiation Device Associated with Complications   Common transplant drug inhibits breast cancer growth, UNC laboratory study shows   Estrogen-Lowering Drugs Reduce Mastectomy Rates for Breast Cancer Patients   Metabolic syndrome linked to breast cancer   Low-dose radiation may raise breast cancer risk   Future in which Breast Cancer Will Be Cured or Controlled   Big Bias In Who Gets Screened for Breast Cancer   UBC discovery may lead to ‘smart’ therapies for breast, ovarian cancer   Black Cancer Patients Less Likely than Whites to Receive the End-of-life Care They Prefer   Chicago team uses artificial intelligence to diagnose metastatic cancer   Breast MRI Detects Additional “Unsuspected” Cancers Not Seen on Mammography or Ultrasoun   Breast Cancer Physicians Have Limited Access to Trained Interpreters   European ancestry increases breast cancer risk among Latinas   The significance of the site of recurrence to subsequent breast cancer survival   Mammography screening reduced risk for death from breast cancer by half   New Clues to Breast Cancer Development in High-Risk Women   Error rate higher in breast imaging reports generated by automatic speech recognition   Use of costly breast cancer therapy strongly influenced by reimbursement policy   New model predicts relapse in early breast cancer patients following endocrine therapy   UT Southwestern launches clinical trial for treatment of breast cancer using CyberKnife   MRI cost-effective for some women at high-risk of breast cancer   High-risk, underserved women benefited from MRI screening for breast cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]